Investing.com - Opko Health (NASDAQ: OPK ) reported fourth quarter EPS of $0.010, $0.09 better than the analyst estimate of $-0.080. Revenue for the quarter came in at $103.1M versus the consensus estimate of $156.35M.

Opko Health’s stock price closed at $1.63. It is up 5.840% in the last 3 months and up 65.400% in the last 12 months.

Opko Health saw positive EPS revisions and negative EPS revisions in the last 90 days. See Opko Health’s stock price’s past reactions to earnings here .

According to InvestingPro , Opko Health’s Financial Health score is " fair performance ".

Check out Opko Health’s recent earnings performance , and Opko Health’s financials here .

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar